FierceBiotech

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX® (teduglutide) for the Treatment of Adult Short

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX® (teduglutide) for the Treatment of Adult Short Bowel Syndrome (SBS) BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS ...
Business Wire

NPS Pharmaceuticals Announces FDA Acceptance of Biologics License Application for Natpara® for the Treatment of Hypoparathyroidism

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare ...
FierceBiotech

NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX® (teduglutide) for the Treatment of Adult

BEDMINSTER, N.J.--(BUSINESS WIRE)-- NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today ...